What Has Been the Growth of the Gastroenteritis Testing Market So Far?
The gastroenteritis testing market has seen considerable growth due to a variety of factors.
• The market size of gastroenteritis testing has experienced significant growth in the recent past. The projected increase is from $3.94 billion in 2024, spurting to $4.18 billion in 2025, indicating a compound annual growth rate (CAGR) of 6.2%.
The historical growth is backed by global travel increase, population surge, foodborne illness outbreaks, development in healthcare infrastructure, and multiplication of public health monitoring initiatives.
What Are the Future Growth Projections for the Gastroenteritis Testing Market?
The gastroenteritis testing market is expected to maintain its strong growth trajectory in upcoming years.
• The market for gastroenteritis testing is set to experience robust expansion in the coming years, with predictions pegging it at $5.26 billion by 2029. This signifies a compound annual growth rate (CAGR) of 5.9%.
Factors contributing to this projected expansion over the forecast period include the escalating incidence of waterborne diseases, an increase in health care institutions, the wider application of point-of-care testing kits, a surge in viral infection cases, and a climbing rate of stomach infections. Key trends to watch during this period include advancements in technology, increased use of molecular diagnostics, AI integration, evolution of point-of-care testing, and the rise in telemedicine.
What Are The Core Factors Supporting Growth In The Gastroenteritis Testing Market?
The gastroenteritis testing market is set to witness growth due to an escalating occurrence of bacterial infections. The rise in bacterial infections is attributed to increasing antibiotic resistance, denser populations, and increased global travel allowing the resistant bacteria to spread. To precisely detect the pathogen causing symptoms like diarrhea and vomiting, gastroenteritis testing is crucial. This testing consequently aids in the provision of suitable treatment while restricting the infection's spread. For instance, the European Centre for Disease Prevention and Control, a government agency based in Sweden, reported in February 2024, that there were 4,149 confirmed cases of shigellosis across 30 EU countries in 2022. Notably, 48% of these cases were travel-related. Hence, with an upsurge in bacterial infections, the gastroenteritis testing market continues to expand.
What Are The Major Segments Within The Global Gastroenteritis Testing Market?
The gastroenteritis testing market covered in this report is segmented –
1) By Type: Viral Gastrointestinal Infections, Bacterial Gastrointestinal Infections, Parasitic Gastrointestinal Infections
2) By Disease Strains: Bacterial Strains, Viral Strains, Parasitic Strains
3) By Testing Methods: Immunoassay Testing, Conventional Testing, Molecular Diagnostic Testing
4) By End-User: Hospitals, Clinics Or Medical Centers, Research Institutes, Diagnostic Laboratories
Subsegments:
1) By Viral Gastrointestinal Infections: Norovirus, Rotavirus, Astrovirus, Adenovirus, Sapovirus
2) By Bacterial Gastrointestinal Infections: Escherichia coli (E. coli), Salmonella, Campylobacter, Shigella, Clostridium perfringens
3) By Parasitic Gastrointestinal Infections: Giardia lamblia, Entamoeba histolytica, Cryptosporidium, Trichinella, Strongyloides stercoralis
Pre-Book The Gastroenteritis Testing Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Gastroenteritis Testing Market?
Leading firms in the gastroenteritis testing market are introducing unique products, such as molecular gastrointestinal tests, aiming to provide higher sensitivity and specificity. A molecular gastrointestinal test is a diagnostic tool that employs molecular techniques like polymerase chain reaction (PCR), to identify specific genetic material in pathogens or organisms present in gastrointestinal samples. For example, in June 2024, QIAGEN N.V., a company based in Germany that provides sample and assay technologies, unveiled the QIAstat-Dx Gastrointestinal Panel 2. This panel is remarkable for swiftly and thoroughly discovering up to 16 significant bacterial, viral, and parasitic pathogens that typically cause gastrointestinal infections. Using real-time polymerase chain reaction (PCR) technology, it amplifies multiple genetic targets in one reaction, which is a considerable advancement over conventional microbiological methods that typically take 24 hours to 10 days for sample incubation.
Who Are the Key Players In The Gastroenteritis Testing Market?
Major companies operating in the gastroenteritis testing market are:
• F. Hoffmann-La Roche Ltd.
• Merck & Co. Inc.
• Abbott Diagnostics
• Laboratory Corporation of America Holdings
• Thermo Fisher Scientific Inc.
• Eurofins Scientific SE
• Hologic Inc.
• Becton Dickinson and Company
• bioMérieux SA
• Quest Diagnostics Incorporated
• DiaSorin S.p.A.
• Bio-Rad Laboratories Inc.
• Randox Laboratories Ltd.
• ARUP Laboratories
• Meridian Bioscience Inc.
• MedGenome
• Trinity Biotech plc
• Savyon Diagnostics Ltd.
• Coris BioConcept
• Aster Clinical Research & Diagnostic Centre Pvt. Ltd.
• Alimetrix Inc.
• Luminex Corporation
What Is The Most Dominant Region In The Gastroenteritis Testing Market?
North America was the largest region in the gastroenteritis testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroenteritis testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
